The prognostic value of serum epidermal growth factor receptor level in patients with non-small cell lung cancer

Uncommon epidermal growth factor receptor mutations in non small cell lung cancer an their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and

Primary resistance to epidermal growth factor receptor (EGFR) ty- rosine kinase inhibitors (TKIs) in patients with non-small- cell lung cancer harbouring TKI-sensitive EGFR

This study was approved by University of Health Sciences Turkey, İstanbul Training and Research Hospital Ethics Committee (approval number: 1858, date:

Evaluation of epidermal growth factor receptor mutations and thyroid transcription factor-1 status in Turkish non-small cell lung carcinoma patients: A study of 600 cases from a

Levels of signal peptide- Complement C1r/C1s, Uegf, and Bmp1-epidermal growth factor domain- containing protein 1 in tissue samples were significantly higher in

Conclusion:­ Despite the limited number of the cases in our retrospective study, it was found that in early stage lung cancer the type histology was far more prognostic

Our measurements showed significant differences from control group for Ang-2 levels of patients with lung cancer, but VEGF didn’t show any difference as similar to a study (4)..

In a previ- ously published study, it was shown that endob- ronchial ultrasound (EBUS) with TBNA was highly accurate in staging the mediastinum in patients with non-small cell